Anti-Human CD34 Antibody [QBEnd-10]
Anti-Human CD34 Antibody [QBEnd-10] with collaborator-tested evidence for Flow Cyt. Read more ›
["FCM"]![Anti-Human CD34 Antibody [QBEnd-10]](http://www.abmium.com/cdn/shop/files/Screenshot_2026-06-08_210431_cfc626c1-a3ba-4de6-96ed-99eadfc799f0.png?v=1781036056&width=160)
Product Description
CD34 is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Mouse; clonality: Monoclonal; clone: QBEnd-10; isotype: Mouse IgG1, κ; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for FCM. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Recombinant Human CD34 protein; purification: >98%, Protein A/G purified; concentration: ≥ 1 mg/mL.
Database references: UniProt: P28906 | NCBI Gene: 947.
Research Use Only.
Key Facts
| Target | CD34 |
| Also known as | GIG, MORT, Hematopoietic progenitor cell antigen CD, Gp105, CD34, CD34 molecule, GIG3, MORT1, Gp105-120, My10, Hematopoietic progenitor cell antigen CD34, Mucosialin, CD34, CD34 molecule, GIG3, MORT1, RP11-328D5.2 |
| Concentration | ≥ 1 mg/mL |
| Species reactivity | Human |
| Purity | >98% |
| Shelf life | 12 months from shipping dates |
| Research area | Neuroscience, Immunology, Stem Cells, Cancer, Cardiovascular, Developmental Biology |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | |
|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.